POU5F1 and breast cancer: To the best of our knowledge, the present study revealed for the first time the key role of Oct4 and Nanog in chemotherapeutic resistance and tumor growth in breast CSCs, which provides a possible novel insight into stem cell-based target therapies in breast cancer.